Resveratrol Improves Cardiomyopathy in Dystrophin-deficient Mice through SIRT1 Protein-mediated Modulation of p300 Protein*
Open Access
- 1 February 2013
- journal article
- Published by Elsevier BV in Online Journal of Public Health Informatics
- Vol. 288 (8), 5963-5972
- https://doi.org/10.1074/jbc.m112.392050
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Differential Cell-Protective Function of Two Resveratrol (Trans-3,5,4′-trihydroxystilbene) Glucosides against Oxidative StressThe Journal of pharmacology and experimental therapeutics, 2012
- Acetylation-dependent regulation of endothelial Notch signalling by the SIRT1 deacetylaseNature, 2011
- Clinical trials of resveratrolAnnals of the New York Academy of Sciences, 2011
- Acetylation of Tau Inhibits Its Degradation and Contributes to TauopathyNeuron, 2010
- Myostatin Is Upregulated Following Stress in an Erk-Dependent Manner and Negatively Regulates Cardiomyocyte Growth in Culture and in a Mouse ModelPLOS ONE, 2010
- Interdependence of AMPK and SIRT1 for Metabolic Adaptation to Fasting and Exercise in Skeletal MuscleCell Metabolism, 2010
- Induction of Manganese Superoxide Dismutase by Nuclear Translocation and Activation of SIRT1 Promotes Cell Survival in Chronic Heart FailureOnline Journal of Public Health Informatics, 2010
- FXR Acetylation Is Normally Dynamically Regulated by p300 and SIRT1 but Constitutively Elevated in Metabolic Disease StatesCell Metabolism, 2009
- Histone deacetylase SIRT1 modulates neuronal differentiation by its nuclear translocationProceedings of the National Academy of Sciences of the United States of America, 2008
- Ubiquitin-Dependent Distribution of the Transcriptional Coactivator p300 in Cytoplasmic Inclusion BodiesEpigenetics, 2007